3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
fludarabine phosphate
18
Peripheral Blood Stem Cell Transplantation
15
Whole-Body Irradiation
14
Mycophenolic Acid
14
Cyclophosphamide
14
Tacrolimus
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Methotrexate
8
Melphalan
7
Etoposide
7
Sirolimus
5
Radiotherapy
5
Filgrastim
5
Cord Blood Stem Cell Transplantation
5
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
Cyclosporins
4
thymoglobulin
3
Methylprednisolone
3
Therapeutics
2
Rituximab
2
Ondansetron
2
Flow Cytometry
2
Dexamethasone
2
Carmustine
2
Carboplatin
2
Calcium Dobesilate
2
Aprepitant
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Imatinib Mesylate
×
Clear all
No trials found.